|
2024
|
Invention
|
Pharmaceuticals and devices for the covalent immobilization to the extracellular matrix by transg... |
|
|
Invention
|
Functionalized nanoparticles for viral clearance. The present invention relates to functionalized... |
|
|
Invention
|
Mhc 1b-mediated alpha-synuclein-specific tolerance induction as a novel treatment for parkinson's... |
|
|
Invention
|
Mhc ib-mediated myelin-specific immunosuppression as a novel treatment for multiple sclerosis and... |
|
|
Invention
|
Mhc ib-mediated aquaporin 4 (aqp4)-specific immunosuppression as a novel treatment for nmo. The p... |
|
|
Invention
|
Modulation of presynaptic pathology with munc13-1 local translation. This application includes a ... |
|
|
Invention
|
Treatment of spinal muscular atrophy (sma) and other motor neuron diseases by causing presynaptic... |
|
|
Invention
|
Multivalent single-partite antibodies for dual-antigen restricted immunotherapy. The present inve... |
|
|
Invention
|
Modified human lymphocytes containing and expressing positive regulators of autophagy. The presen... |
|
|
Invention
|
Strategies to target extracellularly accessible ras protein. The invention is based on the findin... |
|
|
Invention
|
Matrix metalloproteinase 13 sensitive peptides and sensors. The present invention relates to diag... |
|
|
Invention
|
System and method for checking the ability of a protein of interest to act as a substrate for an ... |
|
|
Invention
|
Furin sensors and applications thereof. The present invention relates to diagnostic furin sensors... |
|
|
Invention
|
Hbv core protein binding compounds and uses thereof. The present invention relates to a compound ... |
|
|
Invention
|
Device for endovascular drug delivery and use thereof. The present invention relates to a device ... |
|
2023
|
Invention
|
Antibodies for use as coagulants. The present invention provides novel antibodies, fragments or d... |
|
|
Invention
|
Monoclonal antibodies to growth and differentiation factor 15 (gdf-15).
The present invention re... |
|
|
Invention
|
Kit for combination therapy of tumor diseases and/or infections. The present invention relates to... |
|
|
Invention
|
Bead bound anticd28 antibody for the treatment of malignant melanoma. The present invention relat... |
|
|
Invention
|
Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes.
In some embodim... |
|
|
Invention
|
Compounds for detection of oral inflammation. The present invention relates to novel protease-sen... |
|
|
Invention
|
Anti-cd40 antibody constructs with high intrinsic agonism. The present invention relates to oligo... |
|
|
Invention
|
Method for the preservation of functional gametes. The present invention relates to the use of ca... |
|
|
Invention
|
Receptacle, device for releasing carbon monoxide, treatment system, set for treating living cells... |
|
|
Invention
|
Monoclonal antibodies to growth and differentiation factor 15 (gdf-15), and usesthereof for treat... |
|
|
Invention
|
Transposase fusion proteins for use in cell and gene therapy. Fusion proteins and methods for con... |
|
|
Invention
|
Combinations of mhc class ib molecules and peptides for targeted therapeutic immunomodulation.
T... |
|
|
Invention
|
Antibody-based soluble and membrane-bound tweak mimicking agonists with fcyr-independent activity... |
|
|
Invention
|
Novel recombinant fibrinogen variants for fibrin sealants for surgical wound care. The invention ... |
|
|
Invention
|
Anti-gdf15 antibody and a dosage regimen for the treatment of cancer.
The present invention rela... |
|
|
Invention
|
Gdf-15 as a diagnostic marker for melanoma.
The present invention relates to methods for predict... |
|
|
Invention
|
Metal-organic frameworks as solid self-microemulsifying drug delivery systems. The present invent... |
|
|
Invention
|
Mhc ib-mediated islet-antigen-specific immunosuppression as a novel treatment for type 1 diabetes... |
|
|
Invention
|
Method and molecules for reducing axonal tau protein accumulation through blocking of hnrnp r-med... |
|
|
Invention
|
A method and system for measuring a modified property of a sample comprising magnetic particles i... |
|
2022
|
Invention
|
A substituted aromatic dicarbonic acid amide as an inhibitor of the ferroptosis suppressor protei... |
|
|
Invention
|
Control and modulation of the function of gene-modified chimeric antigen receptor t cells with da... |
|
|
Invention
|
Light-driven nanodrones.
The present invention relates to a nanodrone, a method of operating a n... |
|
|
Invention
|
Antibodies against candida albicans proteins and their therapeutic and prophylactic use for treat... |
|
|
Invention
|
Recombinant proteinaceous binding molecules.
The present invention relates to a recombinant prot... |
|
|
Invention
|
Device for fabricating a perfusable three-dimensional tissue construct.
A device for fabricating... |
|
|
Invention
|
Novel tnfr2 binding molecules.
The present invention provides a binding molecule that specifical... |
|
|
Invention
|
Inverse thermogelling polyoxazoline copolymers.
Provided is a block copolymer comprising a polym... |
|
|
Invention
|
Flexible implant for fixating a disjoined pubic symphysis.
The invention refers to an implant de... |
|
2021
|
Invention
|
Biocompatible composite membrane, method for fabricating the membrane, bioreactor and method for ... |
|
|
Invention
|
Modified lymphocytes.
The present invention relates to a lymphocyte, modified to exhibit a reduc... |
|
|
Invention
|
Combination therapy of atra or other retinoids with immunotherapeutic agents binding to bcma.
Th... |
|
2020
|
Invention
|
Membrane-based two component therapeutic gas release system for oral administration.
The present... |
